Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress
Clinical trial NCT04606784 · COMPLETED
Trial details
- NCT number
- NCT04606784
- Sponsor
- Ampio Pharmaceuticals. Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2021-06-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.